← Retour à la une
États-Unis · Bourse & Finance · Yahoo Finance

MannKind Data at HFSA 2026 Highlights New Evidence Supporting Furoscix ReadyFlow™ for the Outpatient Management of Edema in Heart Failure (HF) and Chronic Kidney Disease (CKD)

Publié par Yahoo Finance · États-Unis il y a 11 h

Data presentations build on the July 2026 FDA approval and U.S. launch of Furoscix ReadyFlow, the first and only autoinjector delivering IV-equivalent diuretic therapy for heart…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

À lire aussi

TechCrunch

Anthropic can’t reliably control its AI agents. It’s cutting off its internal evals from the live internet instead

 Business Insider

An NYU professor says OpenAI's mass release of math papers wiped out early-career researchers' projects

 Seeking Alpha

Trump turns to Russia in bid to lower diesel prices, but analysts see minimal impact

 CNBC

Trump's diesel agreement with Putin accused of contradicting Russia sanctions law

 NYT Business

Big Controversy Upends a Contest About Microscopic Videos

 OilPrice.com

Why Record Crude Output Can’t Solve America’s Diesel Crisis